161 related articles for article (PubMed ID: 33437359)
1. Ahypoxia-related signature enhances the prediction of the prognosis in hepatocellular carcinoma patients and correlates with sorafenib treatment response.
Jiang HY; Ning G; Wang YS; Lv WB
Am J Transl Res; 2020; 12(12):7762-7781. PubMed ID: 33437359
[TBL] [Abstract][Full Text] [Related]
2. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract][Full Text] [Related]
3. A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.
Chen Y; Zhu Y; Dong Y; Li H; Gao C; Zhu G; Mi X; Li C; Xu Y; Wang G; Cai S; Han Y; Xu C; Wang W; Yang S; Ji W
Front Oncol; 2023; 13():1085188. PubMed ID: 37051536
[TBL] [Abstract][Full Text] [Related]
4. Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients.
Ning G; Li Y; Chen W; Tang W; Shou D; Luo Q; Chen H; Zhou Y
J Oncol; 2021; 2021():9949492. PubMed ID: 34335764
[TBL] [Abstract][Full Text] [Related]
5. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z
Front Genet; 2022; 13():823443. PubMed ID: 35368686
[No Abstract] [Full Text] [Related]
6. Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma.
Li Q; Jin L; Jin M
Front Genet; 2021; 12():613890. PubMed ID: 34194464
[TBL] [Abstract][Full Text] [Related]
7. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
[TBL] [Abstract][Full Text] [Related]
8. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
9. Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection.
Zheng L; Gu X; Zheng G; Li X; He M; Liu L; Zhou X
PeerJ; 2021; 9():e12554. PubMed ID: 34900444
[TBL] [Abstract][Full Text] [Related]
10. Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma.
Hu B; Yang XB; Sang XT
J Hepatocell Carcinoma; 2020; 7():315-330. PubMed ID: 33204664
[TBL] [Abstract][Full Text] [Related]
11. Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma.
Cheng Z; Huang H; Li M; Liang X; Tan Y; Chen Y
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242427
[TBL] [Abstract][Full Text] [Related]
12. An Angiogenic Gene Signature for Prediction of the Prognosis and Therapeutic Responses of Hepatocellular Carcinoma.
Ci H; Wang X; Shen K; Du W; Zhou J; Fu Y; Dong Q; Jia H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834736
[TBL] [Abstract][Full Text] [Related]
13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
14. Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma.
Tang C; Ma J; Liu X; Liu Z
PeerJ; 2020; 8():e9774. PubMed ID: 32953265
[TBL] [Abstract][Full Text] [Related]
15. A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.
Huo J; Cai J; Guan G; Liu H; Wu L
Front Cell Dev Biol; 2021; 9():761839. PubMed ID: 34869350
[No Abstract] [Full Text] [Related]
16. Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Xie WX; Zhang CY; Xu JW
J Cell Physiol; 2020 Feb; 235(2):1624-1636. PubMed ID: 31309563
[TBL] [Abstract][Full Text] [Related]
17. A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma.
Su L; Zhang G; Kong X
Front Oncol; 2021; 11():642563. PubMed ID: 34336648
[TBL] [Abstract][Full Text] [Related]
18. A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma.
Liang Q; Ye Y; Li E; Fan J; Gong J; Ying J; Cao Y; Li R; Wang P
Transl Cancer Res; 2023 Oct; 12(10):2493-2507. PubMed ID: 37969365
[TBL] [Abstract][Full Text] [Related]
19. Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8
Zou Y; Chen Z; Han H; Ruan S; Jin L; Zhang Y; Chen Z; Ma Z; Lou Q; Shi N; Jin H
Front Mol Biosci; 2021; 8():602227. PubMed ID: 33816550
[No Abstract] [Full Text] [Related]
20. A Novel and Robust Prognostic Model for Hepatocellular Carcinoma Based on Enhancer RNAs-Regulated Genes.
Zhang W; Chen K; Tian W; Zhang Q; Sun L; Wang Y; Liu M; Zhang Q
Front Oncol; 2022; 12():849242. PubMed ID: 35646665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
